Found 27 matching trials
Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma PHASE2 The purpose of this study is to evaluate the efficacy and toxicity of tande...
Show More Location
Multiple Locations
Learn More & Join Trial
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma N/A This is an expanded access protocol/compassionate use single institution st...
Show More Location
Cohen Children's Medical Center
Learn More & Join Trial
MCT for the Harvard/UCSF ROBIN Center NA The goal of the Molecular Characterization Trial (MCT) is to obtain biologi...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma N/A Currently there is no known effective treatment for patients with advanced ...
Show More Status
No Longer Available
Location
Cincinnati Children's Hospital Medical Center
Learn More & Join Trial
A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors PHASE2 This is an ongoing prospective Phase II clinical trial evaluating the effic...
Show More Learn More & Join Trial
124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study EARLY_PHASE1 This is a pilot study with the primary purpose to describe organ dosimetry ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma PHASE2 The purpose of this research study is to find how active and safe 131 I-MIB...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) PHASE3 This phase III trial studies iobenguane I-131 or lorlatinib and standard th...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma PHASE1 This is a pilot study to determine whether doses of 15 mCi/kg and 18 mCi/kg...
Show More Location
University of California, San Francisco
Learn More & Join Trial
131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat PHASE2 This study will compare three treatment regimens containing metaiodobenzylg...
Show More Location
Childrens Hospital Los Angeles
Learn More & Join Trial